Lung Cancer
Volume 69, Issue 3 , Pages 307-314, September 2010

Estimation of an optimal chemotherapy utilisation rate for lung cancer: An evidence-based benchmark for cancer care

  • Susannah Jacob

      Affiliations

    • Collaboration for Cancer Outcomes Research and Evaluation (CCORE), Liverpool Hospital and Faculty of Medicine, University of New South Wales, Sydney, Australia
    • Corresponding Author InformationCorresponding author at: Collaboration for Cancer Outcomes Research and Evaluation (CCORE), Liverpool Hospital, Locked Bag 7103, Liverpool, Sydney, NSW 1871, Australia. Tel.: +61 2 9828 6542; fax: +61 2 9828 6670.
    • ,
  • Elizabeth Hovey

      Affiliations

    • Department of Medical Oncology, Prince of Wales Hospital, Sydney, Australia
    • ,
  • Weng Ng

      Affiliations

    • Collaboration for Cancer Outcomes Research and Evaluation (CCORE), Liverpool Hospital and Faculty of Medicine, University of New South Wales, Sydney, Australia
    • ,
  • Shalini Vinod

      Affiliations

    • Collaboration for Cancer Outcomes Research and Evaluation (CCORE), Liverpool Hospital and Faculty of Medicine, University of New South Wales, Sydney, Australia
    • ,
  • Geoff P. Delaney

      Affiliations

    • Collaboration for Cancer Outcomes Research and Evaluation (CCORE), Liverpool Hospital and Faculty of Medicine, University of New South Wales, Sydney, Australia
    • ,
  • Michael B. Barton

      Affiliations

    • Collaboration for Cancer Outcomes Research and Evaluation (CCORE), Liverpool Hospital and Faculty of Medicine, University of New South Wales, Sydney, Australia

Received 15 September 2009; received in revised form 24 November 2009; accepted 29 November 2009. published online 18 January 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0169-5002(09)00594-7

doi:10.1016/j.lungcan.2009.11.017

Lung Cancer
Volume 69, Issue 3 , Pages 307-314, September 2010

Article Tools

* Image Usage & Resolution